Lonza Small Molecules
Save the date

Meet us at

AAPS 2022 PHARMSCI 360

16-19 October 2022
Boston Convention & Exhibition Center
Boston, MA

Lonza Small Molecules is excited to be back in-person at AAPS PharmSci 360 this year. Join our experts for speaking sessions and view our scientific posters online and during the poster presentations.

 

Looking for a CDMO for your next project? Schedule a meeting with our business development team at the show. 

 

Your molecule is our number one priority.  At AAPS and always, we work as one.

Expert presentations


Rapid Fire Session: Inhaled Delivery of Lung Cancer Therapeutics for Optimizing Local Dosing


Monday, October 17, 2022
3:30 PM – 3:45 PM ET
Location: 205 AB

While inhaled chemotherapy has been evaluated for many decades, most clinical trials failed due to various reasons, that may include poor dosage form design disregarding physiological structure of lungs, minimal attention to maximize tumor penetration, need to administer large doses, issues related to safety of medical staff due to aerosol contamination. 
This presentation will provide an insight into current developmental domain for inhaled therapeutics for lung cancer, including novel delivery systems, new delivery devices, and novel formulation and targeting approaches.

Meet the Expert

David Lyon

David Lyon

Sr. Fellow, Global R&D

Lonza Small Molecules

Chalk Talk Session: Improving Oral Absorption to Rapidly Advance Early Phase Compounds


Tuesday, October 18, 2022
11:15 AM – 12:00 PM ET
Location: Spotlight Stage 2, Exhibit Hall A&B

Amorphous solid dispersions (ASDs) are an important formulation strategy for improving oral absorption of poorly water-soluble drugs. To achieve robust ASD drug products, pharmaceutical scientists must design ASD formulations to attain several key attributes including in vivo performance, stability, and manufacturability while minimizing dosage form size. Combining knowledge of key drug, polymer and gastrointestinal properties together with an in vitro and in silico toolkit is critical for achieving key ASD attributes while reducing development timelines and drug substance requirements.

Meet the Expert

Deanna Mudie

Deanna Mudie

Associate Fellow, Global R&D; Sr. Principal Scientist

Lonza Small Molecules

Access scientific posters from our experts


Experimental and Theoretical Investigation of Rotary Atomization Dynamics for Control of Lipid Multiparticulate (LMP) Particle Size during Spray Congealing Process

Cody Prather

Cody Prather

Engineering Lead, Multi-particulate Technologies

Super Material-Sparing HME Screening: Simultaneous API Loading and Degradation Predictions

Amanda Pluntze

Amanda Pluntze

Chemistry Lead, Multi-particulate Technologies

Impacts of polymer thermal degradation on in vitro performance of amorphous solid dispersions

Maria Anderson

Maria Anderson

Technical Expert

Amorphous Solid Dispersions

Solid Form Screening and Crystallization Process Development of a Clinical Phase II API 

Abhijeet S. Sinha

Abhijeet S. Sinha

Head of Solid Form Services

Feasibility of Spray Drying Biotherapeutics: A Material Sparing Screening Process

Amanda Pluntze

Amanda Pluntze

Chemistry Lead, Multi-particulate Technologies

Schedule a meeting to discuss your next project


Angela Ameriks

Angela Ameriks

Senior Director, Sales

North America

Elizabeth Crofts

Elizabeth Crofts

Business Development Associate

Amanda Pluntze

Kristel Sauter

Business Development Manager

Eric Blomgren

Eric Blomgren

Director,

Business Development

Elizabeth Herder

Elizabeth Herder

Business Development Associate

 
Lonza

© 2026 Lonza. All rights reserved.